Glenview Capital Management
GLENVIEW CAPITAL MANAGEMENT, LLC · NEW YORK, NY · Quarter end: Sep 30, 2026 · Filed with SEC: Nov 16, 2026 · Open the SEC source ↗Activist Investor
Portfolio Return (1Y)——
Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.$5.63B2026 Q3+ $498.4M options (notional, not included)
Positions140
Top-10 ConcentrationPercent of the portfolio in the 10 largest holdings. High means the fund is concentrated in few stocks.55.8%
AUM History
Quarterly History · 40 Quarter
| Quarter | Filed | Holdings | Total Value | Turnover %Turnover = (value of positions opened + previous value of positions closed + |change in shares| × price for names held in both quarters) / the average portfolio value of the two quarters. Price moves do not count; a quarter with any trade is never 0%. | Top 10 |
|---|---|---|---|---|---|
| 2026 Q3 | 2026-11-16 | 135 | $6.13B | 46.4% | GPN, THC, AMZN, META, TMO, TEVA, A, AMD, DHR, HUM |
| 2026 Q2 | 2026-08-14 | 42 | $5.49B | 63.0% | GPN, CVS, THC, TMO, AMZN, A, DHR, META, AMD, TEVA |
| 2026 Q1 | 2026-05-15 | 41 | $3.98B | 44.5% | CVS, GPN, THC, AMZN, TEVA, CI, AMD, TMO, VTRS, DXC |
| 2025 Q4 | 2026-02-17 | 54 | $4.91B | 35.8% | CVS, TEVA, GPN, THC, AMZN, GTM, VTRS, TMO, DXC, DOCN |
| 2025 Q3 | 2025-11-14 | 53 | $4.49B | 34.2% | CVS, THC, GPN, TEVA, GTM, AMZN, TMO, DXC, UHS, PYPL |
| 2025 Q2 | 2025-08-14 | 42 | $3.57B | 42.8% | CVS, THC, GPN, TEVA, GTM, ALITEUR, AMZN, CI, USFD, DXC |
| 2025 Q1 | 2025-05-15 | 44 | $4.07B | 29.6% | CVS, THC, GPN, TEVA, ALITEUR, UHS, AMZN, GTM, CI, DXC |
| 2024 Q4 | 2025-02-14 | 36 | $3.96B | 34.3% | CVS, GPN, THC, ALITEUR, TEVA, DUN & BRADSTREET HLDGS INC, CI, EXPE, UHS, DXC |
| 2024 Q3 | 2024-11-14 | 43 | $5.17B | 38.3% | CVS, THC, GPN, CI, CTVA, DXC, CLVT, UHS, EXPE, TEVA |
| 2024 Q2 | 2024-08-14 | 46 | $5.08B | 38.2% | THC, CVS, CI, GPN, CTVA, ALITEUR, UHS, ESI, DXC, MCK |
| 2024 Q1 | 2024-05-15 | 43 | $5.72B | 34.3% | THC, CI, CTVA, UHS, GPN, ALITEUR, DXC, ESI, CLVT, MCK |
| 2023 Q4 | 2024-02-14 | 41 | $4.68B | 33.1% | CI, THC, DXC, UHS, GPN, CLVT, CTVA, ALITEUR, MCK, FISV |
| 2023 Q3 | 2023-11-14 | 47 | $4.42B | 28.8% | THC, CI, UHS, GPN, DXC, MCK, FISV, CLVT, AMZN, ALITEUR |
| 2023 Q2 | 2023-08-14 | 46 | $4.44B | 32.9% | CI, THC, DXC, UHS, GPN, CLVT, MCK, ALITEUR, CTVA, USFD |
| 2023 Q1 | 2023-05-15 | 53 | $4.56B | 29.2% | CI, THC, FISV, GPN, DXC, MCK, VVV, USFD, ALITEUR, HCA |
| 2022 Q4 | 2023-02-14 | 51 | $4.51B | 32.6% | CI, THC, DXC, FISV, MCK, GPN, USFD, UHS, CCEP, VVV |
| 2022 Q3 | 2022-11-14 | 53 | $4.00B | 30.6% | CI, THC, FISV, DXC, GPN, MCK, APTIV PLC, AMZN, USFD, BAX |
| 2022 Q2 | 2022-08-11 | 53 | $4.00B | 31.2% | CI, THC, GPN, DXC, MCK, FISV, CCEP, USFD, BAX, APTIV PLC |
| 2022 Q1 | 2022-05-16 | 58 | $4.94B | 39.9% | THC, CI, GPN, MCK, DXC, FISV, BHC, BAX, USFD, CCEP |
| 2021 Q4 | 2022-02-14 | 54 | $4.69B | 38.9% | THC, MCK, BHC, GPN, CI, BAX, DXC, CCEP, COR, HCA |
| 2021 Q3✎ amendment applied | 2021-11-15 | 60 | $5.51B | 30.1% | THC, BHC, MCK, CI, COR, GPN, WTW, DXC, BAX, GOOGL |
| 2021 Q2✎ amendment applied | 2021-08-16 | 65 | $6.05B | 45.1% | THC, BHC, CI, MCK, DXC, 0VVB, COR, GPN, TAK, UHS |
| 2021 Q1 | 2021-05-17 | 63 | $5.90B | 54.9% | THC, BHC, CI, MCK, DXC, TAK, COR, HCA, UHS, META |
| 2020 Q4 | 2021-02-16 | 54 | $4.36B | 30.1% | THC, BHC, TAK, DXC, CI, HCA, MCK, LABORATORY CORP AMER HLDGS, LYFT, NUANEUR |
| 2020 Q3 | 2020-11-16 | 45 | $3.19B | 28.8% | THC, TAK, BHC, CI, HCA, MCK, DXC, LABORATORY CORP AMER HLDGS, HO1, 0VVB |
| 2020 Q2 | 2020-08-14 | 43 | $3.63B | 51.6% | THC, TAK, BHC, CI, HCA, DXC, MCK, 0VVB, NUANEUR, LABORATORY CORP AMER HLDGS |
| 2020 Q1 | 2020-05-15 | 44 | $3.68B | 66.7% | TAK, THC, CI, BHC, HCA, MCK, IQV, FMC, DXC, HO1 |
| 2019 Q4 | 2020-02-14 | 50 | $11.42B | 37.4% | HCA, CI, THC, 0VVB, TAK, IQV, HO1, MCK, BHC, DXC |
| 2019 Q3 | 2019-11-14 | 49 | $9.51B | 30.0% | CI, HCA, MCK, IQV, TAK, THC, HO1, HUM, FMC, DXC |
| 2019 Q2 | 2019-08-14 | 46 | $11.03B | 20.4% | CI, HCA, IQV, FMC, MCK, DXC, HO1, TAK, HUM, FIRST DATA CORP NEW |
| 2019 Q1 | 2019-05-15 | 45 | $11.21B | 58.3% | DXC, FMC, CI, MCK, IQV, HCA, TAK, HO1, THC, GOOGL |
| 2018 Q4 | 2019-02-14 | 48 | $10.33B | 50.3% | SHIRE PLC, FMC, IQV, HCA, CVS, CI, MCK, DXC, GOOGL, DOWDUPONT INC |
| 2018 Q3 | 2018-11-14 | 57 | $15.74B | 26.8% | EXPRESS SCRIPTS HLDG CO, FMC, AETNA INC NEW, IQV, MCK, DOWDUPONT INC, HCA, TMO, FIRST DATA CORP NEW, SHIRE PLC |
| 2018 Q2 | 2018-08-14 | 50 | $14.66B | 30.0% | SHIRE PLC, DOWDUPONT INC, FMC, MCK, THC, IQV, AETNA INC NEW, FIRST DATA CORP NEW, HCA, EXPRESS SCRIPTS HLDG CO |
| 2018 Q1 | 2018-05-15 | 53 | $17.10B | 25.9% | HCA, SHIRE PLC, DOWDUPONT INC, FMC, IQV, NWL, MCK, TMO, WBA, FLEX |
| 2017 Q4 | 2018-02-14 | 58 | $18.50B | 47.9% | HCA, DOWDUPONT INC, FMC, SHIRE PLC, IQV, FLEX, ELV, DXC, TMO, MCK |
| 2017 Q3 | 2017-11-14 | 56 | $17.23B | 35.3% | HCA, DOWDUPONT INC, FMC, SHIRE PLC, QUINTILES IMS HOLDINGS INC, ELV, DXC, FLEX, AETNA INC NEW, GOOGL |
| 2017 Q2 | 2017-08-14 | 52 | $15.41B | 37.5% | HCA, FMC, DOW CHEM CO, QUINTILES IMS HOLDINGS INC, ELV, CIGNA CORPORATION, DXC, FLEX, GOOGL, LOW |
| 2017 Q1 | 2017-05-15 | 51 | $15.07B | 26.2% | HCA, HUM, ELV, DOW CHEM CO, FMC, CIGNA CORPORATION, AETNA INC NEW, COMPUTER SCIENCES CORP, QUINTILES IMS HOLDINGS INC, GOOGL |
| 2016 Q4 | 2017-02-14 | 48 | $14.79B | 35.6% | HCA, HUM, ELV, CIGNA CORPORATION, AETNA INC NEW, GOOGL, ABBV, FMC, LABORATORY CORP AMER HLDGS, FLEX |
Share counts are split-adjusted. Time held counts consecutive quarters ending with the latest filing; more than ten years shows as ">10 Years".
Related managers
Five closest superinvestors by Jaccard overlap of tickers held in the latest quarter (computed nightly).
| Manager | Overlap | Shared holdings |
|---|---|---|
| D.E. Shaw & Co | 11.8% | BSX, EAT, BURL, CI, CVS, CVNA, DHR, DOCU +49 |
| Two Sigma Investments | 10.7% | BSX, CI, CVS, CDNS, CVNA, DHR, DOCU, HUM +52 |
| Alyeska Investment Group | 10.5% | BSX, EAT, BRKR, BURL, CVS, CVNA, DHR, HUM +28 |
| Bridgewater Associates (Ray Dalio) | 10.4% | BSX, CI, CVS, DHR, HUM, KLAC, LLY, MRVL +34 |
| Capital Research Global Investors | 10.4% | CI, CVS, CVNA, DHR, HUM, KLAC, LLY, MRVL +18 |
Read the 2026-Q2 quarterly report · 13F Filing Calendar
13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.